Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Dermal Substitute and Topical Negative Pressure in Burns (VAC-M)
This study is currently recruiting participants.
Verified by Association of Dutch Burn Centres, October 2007
Sponsored by: Association of Dutch Burn Centres
Information provided by: Association of Dutch Burn Centres
ClinicalTrials.gov Identifier: NCT00548314
  Purpose

The purpose of this study is to determine whether a treatment of full thickness wounds by the dermal substitute Matriderm, split skin graft and VAC treatment will improve scar quality, demonstrated by a significant increase of skin elasticity parameters after 3 months.

Additionally, an increase of the take of graft and improvement of scar assessment scale, scar colour/pigmentation and time to complete wound closure, is expected.


Condition Intervention Phase
Burns
Other: dermal matrix
Procedure: Split skin graft
Device: VAC therapy
Phase III

MedlinePlus related topics: Burns Scars
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Parallel Assignment, Efficacy Study
Official Title: Application of a Dermal Substitute and Topical Negative Pressure to Improve the Healing of Burn Wounds

Further study details as provided by Association of Dutch Burn Centres:

Primary Outcome Measures:
  • skin elasticity parameters (representing scar quality) [ Time Frame: after 3 months ]

Secondary Outcome Measures:
  • take of graft after 5-7 days, time to complete (>95%) healing, scar assessment scale and scar colour/ pigmentation (Dermaspectrometer) [ Time Frame: after 3 months ]

Estimated Enrollment: 72
Study Start Date: October 2007
Arms Assigned Interventions
1: Experimental
the selected wound will be treated with dermal substitute Matriderm, split skin graft (SSG) and VAC therapy
Other: dermal matrix Device: VAC therapy
2: Experimental
the selected wound will be treated with dermal substitute Matriderm, and split skin graft
Other: dermal matrix
3: Experimental
the selected wound will be treated with split skin graft and VAC therapy
Device: VAC therapy
4: Active Comparator
the selected wound will be treated with split skin graft.
Procedure: Split skin graft

Detailed Description:

The standard therapy for full thickness wounds is transplantation with a split thickness skin graft. However, scars usually develop as a result of this therapy. Previous research has demonstrated an improvement of scar quality if a dermal substitute was applied in combination with a split skin graft in reconstructive wounds, but not so much in burn wounds. One of the problems in burn wounds was the retarded outgrowth of the skin graft when a dermal substitute was applied in a one step procedure with the graft. Since then, application of topical negative pressure has demonstrated that the take and outgrowth of a skin graft can be improved by this technique. It now seems feasible to combine these two technologies in order to improve the quality of healing of burn wounds in the acute phase of healing.

Aim of the study is to investigate if application of a dermal substitute in combination with topical negative pressure can improve the quality of the scar in burn wounds.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Patients >=18 yrs with acute burns/trauma wounds that require skin grafting
  • Minimal study wound surface 10 cm2
  • Maximal study wound surface 300 cm2
  • Maximal TBSA 15% full thickness wounds
  • Informed consent

Exclusion Criteria:

  • Patients with wounds without adequate possibility to apply VAC
  • Immunocompromised patients
  • Infected wounds
  • Pregnant patients
  • Patients who are expected (according to the responsible medical doctor) to be non-compliant to the study protocol. This includes patients with severe cognitive dysfunction/impairment and severe psychiatric disorders (e.g. borderline or depression).
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00548314

Contacts
Contact: Monica Bloemen, MD 0031251625291 mbloemen@rkz.nl

Locations
Netherlands, Noord-Holland
Red Cross Hospital Recruiting
Beverwijk, Noord-Holland, Netherlands, 1942 LE
Contact: Monica Bloemen, MD     0031251265291     mbloemen@rkz.nl    
Principal Investigator: Monica Bloemen, MD            
Sponsors and Collaborators
Association of Dutch Burn Centres
Investigators
Study Director: Esther Middelkoop, Professor Association of Dutch Burn Centres (ADBC)
  More Information

Study ID Numbers: 07.109
Study First Received: October 22, 2007
Last Updated: October 26, 2007
ClinicalTrials.gov Identifier: NCT00548314  
Health Authority: Netherlands: Medical Ethics Review Committee (METC);   Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Keywords provided by Association of Dutch Burn Centres:
Matriderm
Dermal matrix
VAC therapy
Split skin graft
Burns
Scar quality

Study placed in the following topic categories:
Burns
Wounds and Injuries
Disorders of Environmental Origin
Cicatrix

ClinicalTrials.gov processed this record on January 16, 2009